Prestige Consumer Healthcare
PBH
#4654
Rank
NZ$4.12 B
Marketcap
NZ$86.98
Share price
2.62%
Change (1 day)
-33.31%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$6.93

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$7.09. In 2024 the company made an earnings per share (EPS) of NZ$7.57 an increase over its 2023 EPS that were of NZ-$2.83.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.93-8.4%
2024NZ$7.57-367.08%
2023NZ-$2.83-138.33%
2022NZ$7.3911.7%
2021NZ$6.6213.6%
2020NZ$5.83-651.67%
2019NZ-$1.06-148.78%
2018NZ$2.16-83.29%
2017NZ$12.95437.23%
2016NZ$2.41-34.13%
2015NZ$3.6652.94%
2014NZ$2.39-8.11%
2013NZ$2.60
2011NZ$1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.38 116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.30 73.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.36 74.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.35-10.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.88 53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$4.07-42.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.84-3.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$52.13-834.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.15-69.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel